ASX:CSL CSL Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeA$307.61MA: A$307.61▼A$307.6152-Week Range N/AVolume869,289 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.04%BetaN/A ProfileChartCompetitorsDividendEarningsInsider TradesHeadlinesOptions Chain CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. It also operates approximately 140 plasma collection centers. In addition, this segment conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and developsinfluenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for CSL. Previous Next 3.0 Community Rank Outperform VotesCSL has received 203 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCSL has received 140 “underperform” votes. (Add your “underperform” vote.)Community SentimentCSL has received 59.18% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about CSL and other stocks. Vote “Outperform” if you believe CSL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CSL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.8 Dividend Strength Dividend YieldCSL has a dividend yield of 1.04%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCSL does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of CSL is 63.71%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CSL insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$4,892,774.00 in company stock and sold A$0.00 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Growth RatioCSL has a PEG Ratio of 2.43. PEG Ratios above 1 indicate that a company could be overvalued. Previous Next Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.8Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.37 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolASX:CSL Previous Symbol CUSIPN/A CIKN/A Webwww.csl.com.au Phone+61-3-93891911Debt Debt-to-Equity Ratio91.81 Current Ratio3.01 Quick Ratio1.30Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth2.43 Sales & Book Value Annual Sales$9.15 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow207.70 Book ValueA$14.38 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Receive CSL News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. CSL (ASX:CSL) Frequently Asked Questions How were CSL's earnings last quarter? CSL Limited (ASX:CSL) released its quarterly earnings results on Wednesday, August, 14th. The company reported $4.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.22 by $0.01. View CSL's earnings history. How often does CSL pay dividends? What is the dividend yield for CSL? CSL announced a Final dividend on Thursday, August 20th. Shareholders of record on Friday, October 9th will be given a dividend of 1.481 per share on Friday, October 9th. This represents a dividend yield of 0.49%. The ex-dividend date is Thursday, September 10th. This is a boost from CSL's previous Final dividend of A$1.48. View CSL's dividend history. Who are some of CSL's key competitors? Some companies that are related to CSL include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Acrux (ACR), Actinogen Medical (ACW), Adalta (1AD), Admedus (AHZ), Almirall (LBTSF), Amarantus Bioscience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR), Antibe Therapeutics (VBIZF), Aortech International (RUA), Apotheca Biosciences (CBDC) and Arno Therapeutics (ARNI). View all competitors. What other stocks do shareholders of CSL own? Based on aggregate information from My MarketBeat watchlists, some companies that other CSL investors own include BHP Group (BHP), Commonwealth Bank of Australia (CBA), Cochlear (COH), RESMED/IDR UNRESTR (RMD), Telstra (TLS), Woodside Petroleum (WPL), Altium (ALU), Afterpay Touch Group (APT), Appen (APX) and REA Group (REA). Who are CSL's key executives? CSL's management team includes the following people: Mr. Paul R. Perreault, MD, CEO & Exec. Director (Age 62)Mr. David Mark Lamont ACA, BCom, Chief Financial Officer (Age 53)Dr. Robert Andrew Cuthbertson, Chief Scientific Officer & Director of R&D and Director (Age 64)Mr. Gregory Boss BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel (Age 58)Ms. Elizabeth Walker, Exec. VP & Chief HR Officer (Age 49) What is CSL's stock symbol? CSL trades on the ASX under the ticker symbol "CSL." How big of a company is CSL? CSL has a market capitalization of $0.00 and generates $9.15 billion in revenue each year. What is CSL's official website? The official website for CSL is www.csl.com.au. How can I contact CSL? CSL's mailing address is 45 Poplar Road,, Parkville, MELBOURNE, VIC 3052, Australia. The company can be reached via phone at +61-3-93891911. This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
